58 related articles for article (PubMed ID: 5119518)
1. Contribution to elucidation of biochemical action mechanism of Cytembena.
Slavíková V; Semonský M; Slavík K; Zikán V; Bloch A; Veselá H
Neoplasma; 1971; 18(5):455-7. PubMed ID: 5119518
[No Abstract] [Full Text] [Related]
2. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
Veselá H; Jelínek V; Pujman V; Zlatkovská Z
Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
[No Abstract] [Full Text] [Related]
3. Cytembena treatment of advanced gynaecological carcinomas.
Dvorák O
Neoplasma; 1971; 18(5):461-4. PubMed ID: 5119520
[No Abstract] [Full Text] [Related]
4. New cancerostatics developed in Czechoslovakia. Introductory lecture.
Semonský M
Neoplasma; 1971; 18(5):431-4. PubMed ID: 5171223
[No Abstract] [Full Text] [Related]
5. Substances with antineoplastic effect. XLII. The influence of MBA on incorporation of some amino-acids in the proteins of Yoshida ascites rat sarcoma cells.
Veselá H; Kraus P; Semonský M; Slavíková V
Neoplasma; 1970; 17(1):49-52. PubMed ID: 5423433
[No Abstract] [Full Text] [Related]
6. Substances with antineoplastic effect. XL. The influence of sodium salt of beta-4-methoxybenzoyl-beta-bromacrylic acid (MBBA) and some related substances on the respiration of rat liver homogenate and Yoshida ascites rat sarcoma cells; the influence of these substances on the mechanisms of oxidative phosphorylation of the liver homogenate.
Helia O; Jindra A; Semonský M
Neoplasma; 1969; 16(6):597-604. PubMed ID: 5369025
[No Abstract] [Full Text] [Related]
7. [Effect of toxic dose of Cytembena on the rat kidney].
Rehulová E; Bartosová M
Cesk Patol; 1974 Nov; 10(4):180-3. PubMed ID: 4461154
[No Abstract] [Full Text] [Related]
8. [Antineoplastic agents. 44. Nuclear substituted beta-benzoyl-beta-brom(chlor)acryl acids and beta-4-methoxybenzoyl-alpha-bromacryl acid].
Semonský M; Zikán V; Vrba L; Jelínek V; Slavíková V; Slavík K; Kakác B
Pharmazie; 1971 May; 26(5):286-91. PubMed ID: 5563060
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of Cytembena in man.
Grafnetterová J; Schück O; Smahel O; König J; Růzicková S
Neoplasma; 1971; 18(5):447-54. PubMed ID: 5119517
[No Abstract] [Full Text] [Related]
10. Cancerostatic agents. XXXVII. The effect of beta-aroly-beta-halogen acrylic acids on the tetrahydrofolic acid formylase.
Slavíková V; Semonský M; Slavík K; Zikán V; Volejníková J
Biochem Pharmacol; 1969 Jun; 18(6):1455-61. PubMed ID: 5799117
[No Abstract] [Full Text] [Related]
11. Cytembena treatment of advances and relapsing uterine cervix carcinoma.
Dvorák O; Bauer J
Neoplasma; 1971; 18(5):465-6. PubMed ID: 5119521
[No Abstract] [Full Text] [Related]
12. [Mechanism of action of anti-leukemia agents and adverse effects].
Nakamura T; Ueda T
Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1033-9. PubMed ID: 1402252
[No Abstract] [Full Text] [Related]
13. Local effect of Cytembena and Bucky's rays on superficial basaliomas and Bowen's disease.
Trnka J
Neoplasma; 1971; 18(5):467-70. PubMed ID: 5119522
[No Abstract] [Full Text] [Related]
14. [Cytembena Spofa--a new antineoplastic agent].
Semonský M; Zikán V; Veselá H
Cesk Farm; 1973 Sep; 22(7):313-21. PubMed ID: 4582565
[No Abstract] [Full Text] [Related]
15. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
[No Abstract] [Full Text] [Related]
16. Characterization of the transport of neutral amino acids by the calf lens.
Brassil D; Kern HL
Invest Ophthalmol; 1968 Aug; 7(4):441-51. PubMed ID: 5663553
[No Abstract] [Full Text] [Related]
17. Studies on the biochemical mode of action of a cytotoxic methylhydrazine derivative, N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide.
Sartorelli AC; Tsunamura S
Mol Pharmacol; 1966 Jul; 2(4):275-83. PubMed ID: 5968069
[No Abstract] [Full Text] [Related]
18. Effect of 3'-amino-3'-deoxyadenosine on nucleic acid synthesis in Ehrlich ascites tumor cells.
Truman JT; Klenow H
Mol Pharmacol; 1968 Jan; 4(1):77-86. PubMed ID: 5640781
[No Abstract] [Full Text] [Related]
19. Feedback inhibition of purine biosynthesis in adenocarcinoma 755 and sarcoma 180 cells in culture.
Dixon GJ; Dulmadge EA; Brockman RW; Shaddix SC
J Natl Cancer Inst; 1970 Oct; 45(4):681-5. PubMed ID: 5535124
[No Abstract] [Full Text] [Related]
20. [Cytostatically active N-acyloxymethyl compounds].
Schneider F; Keup U; Seeber S
Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):635-40. PubMed ID: 5789878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
